Opioid Use Disorder

Learner Takeaways

Overview of Screening and Brief Intervention content, including BNI steps and MI methods

View PDF » View as a Web Page »


Facilitator Guide

Exercises and strategies for using this simulation as part of a training or education curriculum.

View PDF » View as a Web Page »


Subject Matter Experts

Key subject matter contributors to the content and design of this simulation:

Elizabeth Salisbury-Afshar
Associate Professor, University of Wisconsin, Madison

Maya Doe-Simkins
Technical Expert, JBS International, Inc.


DSM-5 Criteria for OUD

American Psychiatric Association documents diagnostic criteria from the DSM-5

View PDF »

Waiver Training Information

Learn from SAMHSA about the buprenorphine waiver training courses that are required for physicians, nurses, and physician assistants to prescribe and dispense buprenorphine.

Buprenorphine Training »


Attend an eight-hour Medication-Assisted Treatment (MAT) training from PCSS to obtain a DEA-approved waiver to allow the prescription of buprenorphine.

PCSS-MAT Waiver Training »


Pharmacology and counseling for OUD

Learn background information from SAMHSA about Medication-Assisted Treatment (MAT).

Medication and Counseling Treatment »


Explore the National Practice Guideline from ASAM, which addresses all of the FDA-approved medications available to treat OUD.

The ASAM National Practice Guideline »


Resources for talking with OUD patients

Watch videos from the National Institute on Drug Abuse (NIDA) for cutting-edge information about OUD treatment.

NIDA Videos »


Explore SAMHSA’s treatment locator to find the best local treatment services and programs.

SAMHSA Treatment Locator »


Use the Prescription Drug Abuse Policy System (PDAPS) to explore rigorous legal data and detailed policy information related to prescription drug abuse.

PDAPS Site »


Telehealth Best Practices

Best practices for telehealth encounters.

National Council for Behavioral Health site »

AMA Telehealth Quick Guide »


Best practices for treating OUD patients

Learn from SAMHSA about federal legislation, regulations, and guidelines for opioid treatment programs and MAT.

MAT Legislation, Regulations, and Guidelines »


Explore SAMHSA’s official overview of MAT.

MAT Overview »


Download the official SAMHSA overview of the three FDA-approved medications used to treat patients with OUD.

TIP 63 »


Technical Support

(646) 923-8632
Toll Free: (866) 449-8834
support@kognito.com
Mon - Fri 10am to 6pm EST

Support Center »


Products

Other healthcare provider training simulations from Kognito

Kognito Products »


Research

Published studies supporting use of Kognito’s simulations in healthcare provider training, including learning outcomes and real-world behavior change

Kognito Resources »


Use Cases

Representative examples from institutions using Kognito’s simulations to train healthcare providers

Kognito Use Cases »